Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals.
Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, in Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in several therapeutic areas including a specialized business dedicated to treatments for rare diseases.
Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases.
Company’s Keywords:
drug development, marketing, distribution
How Many Employees Does This Company Have?
2200
Which Industry Does This Company Belong To?
pharmaceuticals
What Is the Annual Income?
1902069000
What Is the Technology of All the Company’s Website?
Outlook, JQuery 1.11.1, Mobile Friendly, ASP.NET, Google Font API, Microsoft-IIS, Google Analytics
What Year Was the Company Founded?
1926
Rate us and Write a Review
Own or work here?
Your request has been submitted successfully.
